Filling the gaps: osteogenesis imperfecta.
Graul
Ann I
AI
D000328:Adult; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D002648:Child; D024042:Collagen Type I / Q000235:genetics / Q000378:metabolism; D000090602:Collagen Type I, alpha 1 Chain; D004164:Diphosphonates / Q000627:therapeutic use; D050723:Fractures, Bone / Q000235:genetics / Q000517:prevention & control*; D015316:Genetic Therapy; D006801:Humans; D007223:Infant; D010013:Osteogenesis Imperfecta / Q000235:genetics / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D019379:Teriparatide / Q000627:therapeutic use
D050071:Bone Density Conservation Agents; D024042:Collagen Type I; D000090602:Collagen Type I, alpha 1 Chain; D004164:Diphosphonates; D019379:Teriparatide